| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.006 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |